September 19, 2017 One chance for Glaxo’s triple The UK company's triple combo just got US approval, and now the group must meet rising analyst expectations.
September 08, 2017 Upcoming events – GSK’s triple COPD play and data for Xtandi in earlier stage prostate cancer
